INTRA-CELLULAR THERAPIES, INC.

Lobbying client · New York · filed 2025 to 2025

Biopharmaceutical company

$80,000 Reported spend

3 Filings counted

1 Firms hired

2 Bills named

Spend is reported income plus in-house expenses across 3 filings. Everything on this page is grouped by the client's LDA id (44412), not by name.

Firms hired 1

INTRA-CELLULAR THERAPIES, INC. $80,000 3 filings

Bills named in these filings 2

HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…

2 filings
HR 1990
American Innovation and R&D Competitiveness Act of 2025

1 filing

Reported by year 1 year

2025 $80,000 3 filings

Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 2
SENATE 2

Recent filings 3 total

3TY

INTRA-CELLULAR THERAPIES, INC.

3rd Quarter (July 1 - Sep 30) 2025 · posted Oct 10, 2025

View → Q2

INTRA-CELLULAR THERAPIES, INC.

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $10,000 expenses · posted Jul 21, 2025

View → Q1

INTRA-CELLULAR THERAPIES, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $70,000 expenses · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.